The effects of exercise intervention and to assess its long-term efficacy in preventing subsequent cardiovascular events in patients with type 2 diabetes were little known on randomized controlled trial. Methods: Thirty-eight type 2 diabetic patients (21 men and 17 women) were assigned to either the exercise group (n 21) or the control group without exercise training (n 17) by simple randomization. The exercise training group was scheduled for aerobic and resistance exercise programs for 3 months. After the 3-month, we investigated endothelial function, insulin resistance, adipocytokines and inflammatory markers. The endothelial function was evaluated by examining a flow-mediated endothelium-dependent vasodilatation (FMD). Furthermore, we followed the incidence of cardiovascular events for 24 months. Results: After 3-month, HbA1C was decreased significantly in both groups. FMD was increased from 7.3 4.7% to 10.9 6.2% only in the exercise group ( p 0.05). Long-term follow-up data showed that the control group developed cardiovascular events more frequently than did the exercise group ( p 0.05). Conclusions: Exercise improves endothelial dysfunction independently of glycemic control and insulin sensitivity in patients with type 2 diabetes. The beneficial effects of 3-month exercise to reduce cardiovascular events persist for 24 months. J Atheroscler Thromb, 2010; 17:828-833.
Introduction
Physical exercise has been reported to reduce the incidence of diabetes 1, 2) , and its modification has long been recommended as one of the three main components of diabetic treatments in addition to diet modification and medication 3) . It is well known that regular exercise produces beneficial effects on risk factors of atherosclerosis by improving glycemic control 4) , in-sulin resistance 5) , and dyslipidemia and hypertension 6) , and contributes to reduce cardiovascular morbidity and mortality not only in the general population 7, 8) but also in patients with type 2 diabetes 9, 10) ; however, the mechanisms by which exercise training prevents the progression of atherosclerotic diseases in type 2 diabetes are still unclear, and the effect of exercise on the prognosis of patients with type 2 diabetes remains uncertain.
The purpose of the present study was to investigate the effects of exercise intervention on endothelial function, insulin resistance, adipocytokines and inflammatory markers in patients with type 2 diabetes in a randomized controlled trial. To assess the longterm efficacy of exercise intervention on the prevention of atherosclerotic disorders, we examined the fol-low-up data of the participants after the exercise intervention period.
Methods

Study subjects and intervention protocol
Thirty-eight Japanese patients (21 men and 17 women) with type 2 diabetes, who were admitted to our hospital for treatment of diabetes from August 2002 to January 2004, participated in this study. Patients who had symptomatic coronary artery disease, proliferative diabetic retinopathy, overt proteinuria, autonomic disorder or orthopedic disorders were excluded from this study. The study design was approved by the ethics committee of the National Cardiovascular Center. All participants gave written informed consent.
Study participants were assigned to either the exercise training group (exercise group, n 21) or the group without exercise training (control group, n 17) by simple randomization without the permuted block method. Patients in the exercise group were scheduled for exercise programs 3 − 5 times weekly for 3 months, supervised by physiotherapists. Each session consisted of 10-min warming-up, 20-min aerobic dance, 20-min stationary bicycle riding, 20-min resistance training and 5-min cool-down. The training heart rate was determined according to Karvonen's equation (k 0.6) 11) . Patients in the control group did not take part in the exercise programs. Both groups received comparable dietary and medical intervention after registration for 3 months.
Clinical examination and measurement of exercise capacity and insulin sensitivity
Clinical and metabolic parameters, including exercise capacity and insulin sensitivity, were measured before and after the intervention period. Systolic and diastolic blood pressures were examined after a minimum of 10-min rest in a sitting position. Body mass index (BMI) was calculated as weight in kilograms divided by the square of the height in meters. Blood samples were collected in the morning after a 12-hour overnight fast, and fasting plasma glucose, HbA1C, lipid profiles, serum adiponectin, leptin, and high-sensitivity C-reactive protein (CRP) levels were analyzed. Exercise capacity was determined by cardiopulmonary exercise testing, the details of which have been published elsewhere 11) . Insulin sensitivity was evaluated by the modified steady-state plasma glucose method (SSPG) 12) .
Assessment of endothelial function by flowmediated brachial artery dilatation
Endothelial function was studied by examining the brachial artery response to flow-mediated endothelium-dependent vasodilatation (FMD), according to the method described previously 13) . Briefly, participants were examined after 15-min rest in the fasting state. After baseline diameter of the right brachial artery was measured by ultrasound images, the pneumatic cuff placed around the right forearm was inflated to 220 mmHg to occlude the brachial artery. The cuff was kept inflated for 270 seconds, and then the diameter of the brachial artery was measured for 120 seconds after cuff deflation. FMD was calculated from baseline and maximum diameters of the brachial artery.
Long-term follow-up of clinical events of the diabetic patients
As a post-hoc study, most of the participants (exercise group, n 21; control group, n 17) were followed in our outpatient unit for 24 months after randomization. We accumulated the follow-up data for 24 months and determined new-onset cardiovascular events, including acute myocardial infarction, angina pectoris, cerebral infarction, and cerebral hemorrhage.
Statistical analysis
Analysis was based on the intention-to-treat principle. Data was expressed as the means S.D. To compare the two groups, we used two-tailed unpaired t tests for continuous variables. The differences between the baseline and after 3 months were evaluated by the two-tailed paired t test in each group. Additionally, we analyzed the incidence of cardiovascular events during 24 months after randomization by Kaplan-Meier analysis of the time to cardiovascular events according to exercise intervention. All analysis was conducted using JMP version 6.0 software (SAS Institute Inc., USA). p values below 0.05 were considered statistically significant.
Results
The clinical backgrounds of the two groups are shown in Table 1 . The clinical and metabolic parameters at baseline except for SSPG were not significantly different between the two groups ( Table 2) , while SSPG at baseline in both groups indicated an insulinresistant state. After the 3-month intervention, HbA1C and serum LDL cholesterol levels were decreased and serum HDL cholesterol and serum adiponectin levels were increased in both groups. BMI was significantly Data are the means S.D. p 0.05, Baseline vs. after 3 months in each group. p 0.01, Baseline vs. after 3 months in each group. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FMD, flow-mediated endothelium-dependent vasodilatation; ND, nitroglycerin-induced vasodilatation; FPG, fasting plasma glucose; SSPG, steady state plasma glucose; CRP, C-reactive protein. O2 and FMD were significantly increased only in the exercise group. SSPG was significantly decreased only in the control group. Serum leptin levels were increased only in the control group. There were no significant changes in high-sensitivity CRP levels in both groups.
Thirty-two of the 38 patients (exercise group: n 16, control group: n 16) were followed up until 24 months after randomization. We could not follow up 5 patients in the exercise group and 1 patient in the control group, because they went to other clinics after the 3-month intervention period. In the control group, 1 patient developed angina pectoris and 3 patients developed cerebral infarction. On the other hand, patients in the exercise group had no cardiovascular events (Fig. ) .
Discussion
The present study demonstrated that exercise intervention improved FMD, a surrogate marker of endothelial function, in patients with type 2 diabetes. Moreover, the 24-month follow-up study showed that the 3-month exercise intervention prevented new-onset cardiovascular events.
This study was a randomized controlled study of exercise treatment and was analyzed by intention-to-treat. Medications for diabetes, hypertension and dyslipidemia were provided to both groups comparably. Patients using insulin and sulfonylurea usage decreased and those with diet alone increased in the exercise group. These changes in medication might have affected the results of metabolic parameters.
Patients with type 2 diabetes have a greater incidence of cardiovascular diseases than non-diabetic patients 14) , and they often have endothelial dysfunction 15, 16) . Vascular endothelium plays an important role in the control of vascular tone, and endothelial dysfunction is considered to be an early manifestation of the atherosclerotic process 17) . Several clinical studies have demonstrated that exercise intervention corrects endothelial dysfunction not only in healthy individuals 18) but also in patients with coronary artery disease 19) . A recent study has shown that exercise training improves the indices of glycemic control and endothelial dysfunction in patients with type 2 diabetes 20) ; however, it is unclear whether the amelioration of endothelial dysfunction is independent of glycemic control, because HbA1C is reported to inversely correlate with FMD 21) . In our study, HbA1C was improved in both groups after the 3-month intervention period regardless of exercise training, and SSPG was not significantly improved by exercise intervention. These data suggest that alterations in HbA1C or SSPG levels may not account for the improvement of FMD, implying that physical exercise has a beneficial impact on endothelial function beyond glycemic control and insulin sensitivity. Moreover, our 24-month follow-up study showed that the 3-month exercise intervention prevented newonset cardiovascular events. Few previous studies have investigated the effect of exercise intervention on longterm outcomes in terms of cardiovascular events in a randomized control trial. A previous report suggested that endothelial dysfunction precedes atherosclerosis and future cardiovascular events 22) , and our study supports the relevance of short-term exercise intervention in the management of type 2 diabetes, albeit perhaps only for a certain period.
We also investigated the effect of physical exercise on adipocytokines: adiponectin and leptin. Adiponectin plays an important role in inducing insulin resistance and atherosclerosis 23) , and several studies concerning the effect of physical exercise on serum adiponectin levels have yielded inconsistent findings 5, 24, 25) . Our study showed that serum adiponectin levels were increased in both groups. This result may imply that serum adiponectin is increased by the improvement of glycemic control, regardless of exercise intervention or weight reduction. An anti-diabetic agents, thiazolidinedione, has been reported to increase plasma adiponectin levels 26, 27) , but no patients took thiazolidinediones in our study. Serum leptin levels are positively correlated with total body adiposity 28) and are reported to decrease with weight reduction 29) , but it is controversial whether exercise training decreases serum leptin levels without reduction of body fat mass 24, 30) . In our study, serum leptin levels were not changed in the exercise group and increased in the control group, whereas body weight was decreased only in the exercise group. Patients in the control group might have much less lean body mass than those in the exercise group, but further investigation is needed to settle this issue.
Chronic inflammation is thought to present as an early sign of atherosclerosis 31) . Previous studies have demonstrated that regular physical exercise is associated with low serum CRP levels and exercise intervention reduces serum CRP levels 32) . In the present study, serum high-sensitivity CRP levels were not altered in either group. Since serum CRP levels are influenced by various pro-inflammatory and inflammatory factors and the number of participants in our study was limited, it is difficult to conclude whether exercise intervention affects serum CRP levels.
Our study has several limitations. First, since we had no information on physical activity during the follow-up period, we could not exclude the possibility that the extent of physical exercise affects the prevention of cardiovascular events. Second, the persistence of the increased FMD in the exercise group was unclear, and the amelioration of endothelial dysfunction could not be comfirmed as the major mechanism of the prevention of cardiovascular events in this study. Third, the improvement of endothelial function might have been affected by the exercise group having a higher prevalence of taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers at baseline and after 3 months.
In conclusion, our study demonstrates that exercise intervention has beneficial effects on endothelial function in patients with type 2 diabetes. Our findings also suggest that exercise training exerts anti-atherosclerotic effects independently of glycemic control and insulin sensitivity. Finally, the favorable effects of a 3-month exercise intervention to reduce cardiovascular events may persist for up to 24 months, although further study is necessary for confirm this.
